RA Capital Management has led an oversubscribed USD40,750,000 Series A round of financing in NanoMosaic, the developer of a suite of analyte interrogation technologies which has successfully exported its platform to leading hospitals and institutes.
Insight Partners, Pura Vida Investments, Time BioVentures and Tiger Gene also participated in the fundraising.